CorVel (CRVL) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Revenue for the June quarter rose 11.3% year-over-year to $212 million, with net income up 8.9% to $21.6 million and diluted EPS increasing 10% to $1.25, driven by growth in patient management and network solutions services.
Growth was supported by new account wins, technology investments, and expanded service offerings, including AI and automation initiatives.
Two major new accounts were onboarded, expected to positively impact results in the second half of the year.
Cash and cash equivalents increased to $132 million, with no outstanding borrowings.
Financial highlights
Gross profit improved 15% to $48.2 million, with gross margin rising to 22.7% year-over-year.
Patient management revenue was $139.2 million (up 8.9%), and network solutions revenue was $73 million (up 16%).
Operating income reached $28 million, up from $25.4 million year-over-year.
General and administrative expenses increased to $20.1 million, partly due to the absence of a one-time insurance recovery in the prior year.
Share repurchases totaled $9.5 million for 38,138 shares during the quarter.
Outlook and guidance
New large accounts and technology investments are expected to drive further growth in the second half of the year and beyond.
Management expects general and administrative expenses to remain between 9% and 11% of revenues in future quarters.
Focus remains on cost management, monetization of services, and leveraging technology for efficiency, including AI integration.
Latest events from CorVel
- Revenue and EPS rose, with AI-driven efficiency and strong cash supporting growth.CRVL
Q3 20265 Feb 2026 - Technology-driven care management and financial strength position the firm as a top industry innovator.CRVL
Investor presentation3 Feb 2026 - Revenue up 13% and EPS up 39% year-over-year, with strong cash and AI-driven efficiency.CRVL
Q3 20259 Jan 2026 - Director elections, auditor ratification, and a new stock plan headline a governance-focused agenda.CRVL
Proxy Filing1 Dec 2025 - Six directors and the external auditor are up for shareholder vote at the August 2024 meeting.CRVL
Proxy Filing1 Dec 2025 - Shareholders will elect six directors and ratify the auditor, with a focus on governance and diversity.CRVL
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and a new stock incentive plan.CRVL
Proxy Filing1 Dec 2025 - Double-digit revenue and EPS growth, expanded AI operations, and a debt-free balance sheet.CRVL
Q4 202524 Nov 2025 - Revenue up 7% and EPS up 20%, fueled by network solutions, AI, and strong cash flow.CRVL
Q2 20266 Nov 2025